Alnylam Pharmaceuticals, Inc.

NasdaqGS:ALNY Stock Report

Market Cap: US$18.4b

Alnylam Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ALNY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Feb 24SellUS$1,040,885Yvonne GreenstreetIndividual7,030US$149.03
16 Feb 24SellUS$149,397Tolga TangulerIndividual1,009US$149.03
16 Feb 24SellUS$149,099Jeffrey PoultonIndividual1,007US$149.03
16 Feb 24SellUS$193,666Pushkal GargIndividual1,308US$149.03
04 Aug 23SellUS$753,986Akshay VaishnawIndividual4,057US$189.31
04 Aug 23SellUS$753,986Yvonne GreenstreetIndividual4,057US$189.31
04 Aug 23SellUS$643,037Jeffrey PoultonIndividual3,460US$189.31
04 Aug 23SellUS$643,223Pushkal GargIndividual3,461US$189.31
27 Apr 23SellUS$357,855Pushkal GargIndividual1,839US$197.08
27 Apr 23SellUS$465,464Akshay VaishnawIndividual2,392US$197.08
27 Apr 23SellUS$287,215Tolga TangulerIndividual1,476US$197.08
27 Apr 23SellUS$190,113Jeffrey PoultonIndividual977US$197.08
27 Apr 23SellUS$1,481,811Yvonne GreenstreetIndividual7,615US$197.08

Insider Trading Volume

Insider Buying: ALNY insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALNY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,6720.00528%
State or Government86,6970.0686%
Individual Insiders444,5010.352%
General Public7,532,2175.96%
Institutions118,382,01293.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 78.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.2%
Capital Research and Management Company
23,049,248US$3.3b1.33%0.18%
9.45%
The Vanguard Group, Inc.
11,943,895US$1.7b2.46%0.03%
7.96%
FMR LLC
10,064,110US$1.5b-9.03%0.1%
6.74%
BlackRock, Inc.
8,521,115US$1.2b1.53%0.02%
5.71%
Wellington Management Group LLP
7,214,198US$1.0b12.2%0.17%
5.51%
Baillie Gifford & Co.
6,967,097US$1.0b-14.7%0.45%
5.46%
T. Rowe Price Group, Inc.
6,910,032US$1.0b-5.65%0.1%
2.91%
Dodge & Cox
3,674,310US$533.4m-1.94%0.25%
2.47%
State Street Global Advisors, Inc.
3,118,552US$452.7m7.55%0.02%
2.16%
JP Morgan Asset Management
2,734,230US$396.9m-3.98%0.05%
1.61%
Norges Bank Investment Management
2,039,798US$296.1m101%0.03%
1.52%
Geode Capital Management, LLC
1,926,736US$279.7m4.74%0.02%
1.3%
RTW Investments, LP
1,640,559US$238.1m-2.54%4.19%
0.88%
Avoro Capital Advisors LLC
1,111,111US$161.3m9.89%2.35%
0.74%
Legal & General Investment Management Limited
930,939US$135.1m17.1%0.03%
0.7%
Pictet Asset Management Limited
885,585US$128.6m12%0.09%
0.7%
Bellevue Asset Management AG
885,318US$128.5m-1.01%1.47%
0.66%
UBS Asset Management AG
831,534US$120.7m-1.52%0.02%
0.66%
BNY Mellon Asset Management
828,478US$120.3m0.04%0.02%
0.6%
Northern Trust Global Investments
764,520US$111.0m-4.16%0.02%
0.56%
Amundi Asset Management SAS
711,692US$103.3m15.8%0.02%
0.48%
Loomis Sayles & Company, L.P.
608,728US$88.4m-2.67%0.13%
0.46%
Gilder Gagnon Howe & Co. LLC
587,045US$85.2m-1.33%1.13%
0.43%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
543,411US$78.9m0.79%0.02%
0.43%
Morgan Stanley, Investment Banking and Brokerage Investments
538,749US$78.2m-43.3%0.01%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.